ES8506726A1 - Un procedimiento para la fabricacion de un nuevo compuesto de cefalosporina. - Google Patents

Un procedimiento para la fabricacion de un nuevo compuesto de cefalosporina.

Info

Publication number
ES8506726A1
ES8506726A1 ES529966A ES529966A ES8506726A1 ES 8506726 A1 ES8506726 A1 ES 8506726A1 ES 529966 A ES529966 A ES 529966A ES 529966 A ES529966 A ES 529966A ES 8506726 A1 ES8506726 A1 ES 8506726A1
Authority
ES
Spain
Prior art keywords
compound
formula
procedure
same
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES529966A
Other languages
English (en)
Spanish (es)
Other versions
ES529966A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Pharma Corp
Original Assignee
Tanabe Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co Ltd filed Critical Tanabe Seiyaku Co Ltd
Publication of ES529966A0 publication Critical patent/ES529966A0/es
Publication of ES8506726A1 publication Critical patent/ES8506726A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES529966A 1983-02-22 1984-02-22 Un procedimiento para la fabricacion de un nuevo compuesto de cefalosporina. Expired ES8506726A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58029063A JPS59155391A (ja) 1983-02-22 1983-02-22 新規セファロスポリン誘導体

Publications (2)

Publication Number Publication Date
ES529966A0 ES529966A0 (es) 1985-07-16
ES8506726A1 true ES8506726A1 (es) 1985-07-16

Family

ID=12265902

Family Applications (1)

Application Number Title Priority Date Filing Date
ES529966A Expired ES8506726A1 (es) 1983-02-22 1984-02-22 Un procedimiento para la fabricacion de un nuevo compuesto de cefalosporina.

Country Status (6)

Country Link
US (1) US4547494A (Direct)
EP (1) EP0117109B1 (Direct)
JP (1) JPS59155391A (Direct)
KR (1) KR840007731A (Direct)
DE (1) DE3467579D1 (Direct)
ES (1) ES8506726A1 (Direct)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL69246A (en) * 1982-08-07 1986-07-31 Tanabe Seiyaku Co 7-((2-aminothiazolyl-2-pyrrolidonyl or(piperidonyl)-oxyimino)acetamido)cephem carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
JPS60132983A (ja) * 1983-12-21 1985-07-16 Tanabe Seiyaku Co Ltd チアゾ−ル酢酸誘導体及びその製法
JPS60142987A (ja) * 1983-12-29 1985-07-29 Mochida Pharmaceut Co Ltd セフアロスポリン誘導体
DE150507T1 (de) * 1983-12-29 1987-02-26 Mochida Pharmaceutical Co., Ltd., Tokio/Tokyo Cephalosporinverbindungen, verfahren zu ihrer herstellung und pharmazeutishe praeparate.
JPS6178792A (ja) * 1984-09-26 1986-04-22 Yamanouchi Pharmaceut Co Ltd ７−〔α−（２−アミノ−４−チアゾリル）−α−（４−オキソ−２−アゼチジニル置換イミノ）アセトアミド〕−３−置換メチル−Δ↑３−セフエム−４−カルボン酸およびその製造法
JPS6185392A (ja) * 1984-10-03 1986-04-30 Tanabe Seiyaku Co Ltd セフアロスポリン化合物の新規製法
JPS61171464A (ja) * 1985-01-23 1986-08-02 Dai Ichi Seiyaku Co Ltd オキシイミノ酪酸誘導体の製法
US4840945A (en) * 1985-04-01 1989-06-20 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives
US4758557A (en) * 1985-06-26 1988-07-19 Meiji Seika Kaisha, Ltd. Cephalosporin derivatives and bactericides containing the same
JPS63107989A (ja) * 1986-06-04 1988-05-12 Tanabe Seiyaku Co Ltd セファロスポリン化合物
JPS63132893A (ja) * 1986-11-25 1988-06-04 Mochida Pharmaceut Co Ltd 新規セフアロスポリン誘導体、その製法およびそれらを有効成分とする抗菌剤
US4880798A (en) * 1986-11-25 1989-11-14 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives
AT389701B (de) * 1987-10-08 1990-01-25 Tanabe Seiyaku Co Neue cephalosporinverbindungen und diese enthaltende pharmazeutische zusammensetzungen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2714880A1 (de) * 1977-04-02 1978-10-26 Hoechst Ag Cephemderivate und verfahren zu ihrer herstellung
FR2508458A1 (fr) * 1981-06-29 1982-12-31 Sandoz Sa Nouveaux derives de l'acide cephalosporanique, leur preparation et leur application comme medicaments

Also Published As

Publication number Publication date
ES529966A0 (es) 1985-07-16
EP0117109A2 (en) 1984-08-29
KR840007731A (ko) 1984-12-10
JPS59155391A (ja) 1984-09-04
DE3467579D1 (en) 1987-12-23
EP0117109B1 (en) 1987-11-19
EP0117109A3 (en) 1985-08-28
US4547494A (en) 1985-10-15
JPH0145474B2 (Direct) 1989-10-03

Similar Documents

Publication Publication Date Title
IE57200B1 (en) Dopamine-beta-hydroxylase inhibitors
ES8506726A1 (es) Un procedimiento para la fabricacion de un nuevo compuesto de cefalosporina.
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
UA27749C2 (uk) Заміщені циклопропіламіно-1,3,5-триазини, їх оптичні ізомери, рацемічні суміші чи їх солі приєднання нетоксичних фармацевтично прийнятних кислот, що мають фармакологічну активність, спосіб їх одержання (варіанти) та фармацевтична композиція на їх основі
ES477832A1 (es) Un procedimiento para la preparacion de derivados de diben- zopirano.
ES8506730A1 (es) Un procedimiento para preparar nuevos compuestos de cefem.
IT8348006A0 (it) Loro produzione derivati cefalosporinici e composizioni antibatteriche che li contengono, nonche' procedimento per la
FI940696A0 (fi) Uudet pyratsiinijohdannaiset, niiden valmistus ja käyttö
WO1990009993A3 (en) Method for the synthesis of huperzine a and analogs thereof and compounds useful therein
ES8401960A1 (es) Procedimiento para la preparacion de imidazolilfenil-tetrahidropiridazinas.
ES8502099A1 (es) Procedimiento de obtencion de nuevos compuestos derivados de la difenil-metilen-etilamina.
JPS5777689A (en) Novel cephen compound, or its salt, its preparation, and preventive it as active ingredient
ES8605532A1 (es) Un procedimiento para preparar derivados de aminoglicosido
ES8502121A1 (es) Derivados del acido 7 b-((z)-2-(2-aminotiazol-4-il)-2-oximinoacetamido)-3-cefem-4-carboxilico
ATE87313T1 (de) Cephemverbindungen, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
ITRM910430A1 (it) Composizioni farmaceutiche di somatostatina con assorbimento migliorato, loro preparazione e loro impiego
ES8600309A1 (es) Un procedimiento para preparar un isomero sin de un compuesto de cefem
ES8405779A1 (es) Un procedimiento para preparar derivados de 1-fenoxi-3-(4-fenilpiperazino)-2-propanol.
AU569013B2 (en) 2-phenoxymethyl-imidazoline derivatives
JPS57200361A (en) "indomethacin(r)" pharmaceutical with low irritant action
ES8400397A1 (es) Un procedimiento para la preparacion de un nuevo peptido activo.
ES2000182A6 (es) Procedimiento para la obtencion de (iso) ureas substituidas potenciadoras del rendimiento.
ES8300747A1 (es) Procedimiento para la preparacion de derivados de acido in- dolacetico
ES8304925A1 (es) Un procedimiento para la preparacion de nuevos derivados del acido &-glutamil-diaminopimelilo.
ES8302719A1 (es) Un procedimiento para preparar compuestos de cefem